Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23682,969,1.27 [1.15-1.42],7.731027204961648e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,23597,189,1.64 [1.34-2.02],2.524923607200849e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,25554,186,1.37 [1.09-1.71],0.0059528127847634
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18051,746,1.47 [1.30-1.66],2.723073301618343e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24450,83,1.52 [1.10-2.12],0.0124497183778035
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,23843,63,1.59 [1.11-2.28],0.0114616071097866
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26252,116,1.35 [1.01-1.81],0.0405967083799288
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26206,70,1.66 [1.18-2.33],0.0032930541056158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,26986,74,1.72 [1.26-2.35],0.0006898522576251
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",25820,429,1.31 [1.12-1.53],0.0005437810653315
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25521,130,1.34 [1.02-1.77],0.0362342470153861
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,25688,297,1.33 [1.11-1.60],0.0021341084635724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22093,50,1.80 [1.26-2.59],0.0013053353699697
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23955,408,1.38 [1.18-1.61],5.745228874334151e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22465,903,1.27 [1.14-1.42],2.3670069171968025e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24831,883,1.14 [1.02-1.28],0.0263713398355715
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26141,58,1.94 [1.42-2.65],2.767113713180919e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22274,712,1.27 [1.12-1.44],0.0002309267518307
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21644,82,1.44 [1.04-2.00],0.0296538643978355
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22222,660,1.26 [1.10-1.44],0.0005632491928338
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,22864,614,1.36 [1.20-1.55],1.817342990262148e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22367,117,1.52 [1.17-1.98],0.0016717007636449
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,25575,35,2.01 [1.38-2.92],0.0002926836893566
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22627,377,1.37 [1.17-1.61],0.000124526103564
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression,25150,337,1.36 [1.15-1.60],0.0003325487717856
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,22411,295,1.41 [1.18-1.69],0.0001824115079346
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,23369,1606,1.14 [1.04-1.24],0.0034685090769601
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26393,421,1.21 [1.03-1.42],0.0206049132302316
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26044,72,1.46 [1.02-2.08],0.0398782804347541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19965,2763,1.11 [1.03-1.20],0.0088029958024795
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,26544,73,1.45 [1.02-2.05],0.03789782946051
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",25465,721,1.22 [1.08-1.38],0.0015043920894338
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,25243,499,1.17 [1.01-1.35],0.0418260128766032
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26539,224,1.39 [1.14-1.70],0.001133588110763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27054,26,1.71 [1.04-2.81],0.0337659814119234
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",24838,94,1.73 [1.32-2.25],5.847433858084828e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25212,478,1.37 [1.19-1.58],1.3735948652002552e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16445,274,1.41 [1.16-1.71],0.0004828587415764
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26165,69,1.56 [1.11-2.19],0.0109486103773939
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26206,110,1.67 [1.29-2.17],0.0001176080270995
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22039,2062,1.29 [1.20-1.40],5.1434231769316986e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,25505,195,1.96 [1.63-2.35],4.284076077151248e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",25487,177,1.89 [1.56-2.29],1.2277465098193363e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26231,223,1.34 [1.09-1.64],0.005409380136461
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26223,215,1.30 [1.05-1.60],0.0138765842440974
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,25881,80,0.64 [0.42-0.98],0.0392142770500853
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24223,1139,1.22 [1.10-1.34],0.0001145903890248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,26070,152,1.79 [1.44-2.22],1.4099208637691168e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26090,172,1.84 [1.50-2.25],4.1016909511527804e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26090,172,1.84 [1.50-2.25],4.1016909511527804e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Asthma,20144,982,1.22 [1.09-1.37],0.0004239580968529
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19958,982,1.22 [1.09-1.37],0.0004475412818202
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20130,968,1.23 [1.10-1.38],0.0002426085027625
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,26802,81,2.80 [2.25-3.49],2.8777371512125716e-20
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,25369,60,3.51 [2.76-4.45],5.7058920030805375e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",26875,60,3.37 [2.68-4.24],4.968178083623307e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25362,53,3.32 [2.57-4.29],3.542219811647921e-20
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,25305,86,1.57 [1.16-2.13],0.0037666301565606
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,25408,189,1.74 [1.43-2.12],3.5078289740214814e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,25970,89,1.56 [1.16-2.10],0.0033433098756787
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22565,2284,1.12 [1.04-1.21],0.0030738775587422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21106,825,1.19 [1.06-1.34],0.0030198920360345
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,23147,66,1.59 [1.11-2.27],0.0111389955016064
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19685,387,1.19 [1.01-1.42],0.0409542850500934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,26335,104,1.36 [1.02-1.83],0.0384834656662719
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,26286,55,1.56 [1.08-2.27],0.0185565039561766
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25558,100,1.37 [1.01-1.85],0.0451044573855342
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26667,454,0.81 [0.68-0.95],0.0124045000500672
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26305,314,1.23 [1.02-1.47],0.0283960551983508
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,26845,52,0.54 [0.31-0.93],0.0260534219062448
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,26842,49,0.53 [0.30-0.94],0.0304087481733338
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26567,354,0.81 [0.67-0.98],0.0332647082935471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19102,4319,1.15 [1.08-1.23],5.318879772364731e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20807,2477,1.10 [1.02-1.19],0.01070405919355
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24343,1318,1.13 [1.03-1.25],0.0086294205264104
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18341,11,2.29 [1.11-4.70],0.0241881782323927
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",26917,11,2.10 [1.10-4.01],0.024728675553784
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19712,1382,1.16 [1.06-1.28],0.0020413916987204
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18745,415,1.22 [1.03-1.44],0.020104256207228
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20216,296,1.39 [1.16-1.66],0.0002709690931394
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26321,216,1.37 [1.10-1.70],0.0042086192937789
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26197,92,1.70 [1.27-2.27],0.0003239425400818
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23420,302,1.41 [1.18-1.67],0.0001307417628579
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24132,1014,1.37 [1.24-1.51],8.610290186640625e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23331,213,1.58 [1.30-1.91],4.396982506273868e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23928,810,1.35 [1.20-1.50],1.991739806345245e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23279,161,1.42 [1.12-1.80],0.0040909612050876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23470,352,1.43 [1.21-1.67],1.5748046728556424e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23299,274,1.30 [1.07-1.57],0.0075311431442728
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23162,137,1.32 [1.02-1.72],0.0365411845692426
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23311,286,1.28 [1.06-1.54],0.0095202845733246
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24407,234,1.25 [1.01-1.54],0.0410571691901
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24652,479,1.19 [1.02-1.39],0.0235710747816688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24212,39,1.85 [1.24-2.74],0.0023733247918381
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24865,35,1.82 [1.19-2.80],0.0059977564383192
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26746,542,1.23 [1.06-1.42],0.0047805735659761
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26445,241,1.39 [1.14-1.71],0.0012398231295724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20336,144,1.49 [1.17-1.91],0.0012017449480255
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27107,863,0.83 [0.73-0.96],0.0089628080411913
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27112,1171,0.76 [0.67-0.86],1.7437600620431966e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26393,149,0.63 [0.46-0.87],0.0047082687238183
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26168,227,0.74 [0.57-0.96],0.0238007079250836
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26364,423,0.75 [0.62-0.91],0.0034216741525991
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26591,650,0.79 [0.67-0.93],0.0037384707522834
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27129,165,0.74 [0.54-0.99],0.0461184366341122
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25700,126,0.69 [0.49-0.97],0.0334564984301003
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27137,332,0.80 [0.65-0.99],0.0411633597512242
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24256,633,1.16 [1.01-1.32],0.0333797972277226
